Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women11
- An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind11, 12
- Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)13
- The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 11, 14
- Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy15
- Imvaggis is very well tolerated13